Adjunctive memantine for opioid use disorder treatment: A systematic review. Elias AM, Pepin MJ, Brown JN. J Subst Abuse Treat. 2019 Dec;107:38-43. doi: 10.1016/j.jsat.2019.10.003. https://www.ncbi.nlm.nih.gov/pubmed/31757263

Fentanyl assisted treatment: a possible role in the opioid overdose epidemic? Bardwell G, Wood E, Brar R. Subst Abuse Treat Prev Policy. 2019 Nov 11;14(1):50. doi: 10.1186/s13011-019-0241-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849248/

Sustained-release Oral Hydromorphone for the Treatment of Opioid Use Disorder. Braithwaite V, Fairgrieve C, Nolan S. J Addict Med. 2019 Oct 25. doi: 10.1097/ADM.0000000000000585.  Abstract https://www.ncbi.nlm.nih.gov/pubmed/31658114

Neue Substitutionsprodukte, neue Chancen? Der Wurm muss dem Fisch schmecken, nicht dem Angler (Präsentation) Dr. Manfred Nowak, Landau NaSuKo – 5.Nationale Substitutionskonferenz, 27.09.2019, Berlin https://www.akzept.eu/wp-content/uploads/2019/1…

Current status of opioid addiction treatment and related preclinical research. Kreek MJ, Reed B, Butelman ER. Sci Adv. 2019 Oct 2;5(10):eaax9140. doi: 10.1126/sciadv.aax9140. eCollection 2019 Oct. Review. https://www.ncbi.nlm.nih.gov/pmc/articles…

Norwegen. 'The entire pharmaceutical compendium' in the treatment of substance use disorders Jørg Mørland, Helge Waal Tidsskr Nor Legeforen 2019, doi: 10.4045/tidsskr.18.0678 https://tidsskriftet.no/en/2019/02/kronikk/entire-pharmaceutical-compen…